Where the practitioners are
Updated
On this page5
This category has an unusually large amount of confident public advice and an unusually small amount of it worth following.
Three groups
Other small brands, useful on packaging suppliers, testing laboratories, marketplace mechanics and what actually sells.
Ingredient suppliers, whose technical teams know their materials properly and will answer formulation and stability questions from a serious buyer.
Contract laboratories, who will explain an assay result and tell you what test you actually needed.
The contract manufacturers know most
Worth naming separately. A contract manufacturer operating under 21 CFR 111 has a quality system, a laboratory relationship and years of experience of exactly the failures you are trying to avoid.
Even if you never use one, a conversation with one is among the most efficient education available in this category, and they are usually willing to have it with a brand that might become a customer.
Where the regulatory answers are
FDA publishes the Dietary Supplement Labeling Guide and the cGMP rule directly, and both are clearer than their reputation. For anything near the claims line, a regulatory consultant rather than a forum.
Trade associations in this space also publish useful material on ingredient standards and testing practice.
What to be careful of
Advice that identity testing is unnecessary at small scale. It is not; the rule has no size threshold.
Advice that a supplier certificate is sufficient on its own. It is evidence, not compliance.
Formulation advice that treats a proprietary blend as a way to avoid declaring amounts, which is a transparency decision customers increasingly see through.
And any claim that a supplement treats a condition, which is a regulatory statement being made casually and is the fastest way into serious trouble here.